Will Herrington is Professor of Clinical Trials and Epidemiology of Kidney Disease at Oxford Population Health, University of Oxford, and is a practising Honorary Consultant Nephrologist at Oxford Kidney Unit. He jointly leads the Renal Studies Group which he joined in 2010 as a Clinical Research Fellow and trained on landmark renal trials (SHARP, 3C and UKHARP3). He is Chief Investigator of the EMPA-KIDNEY and EASi-KIDNEY trials. He co-chairs national and international clinical practice guideline groups, including the 2026 ESC Guideline for the Management of CV disease in Chronic Kidney Disease.